Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Webster LK. Eur J Clin Pharmacol. Jan 1984; 27(3): 341-3
Pubmed [2427]
Wedam EF. Arch Intern Med. Dec 2007; 167(22): 2469-75
Pubmed [12]
Weddington WW Jr. Psychosomatics. Oct 1982; 23(10): 1076-8
Pubmed [7474]
Wee TC. Am J Phys Med Rehabil. Nov 2017; 96(11): e201-e203
Pubmed [4894]
Weeke P. Clin Pharmacol Ther. Jul 2012; 92(1): 72-9
Pubmed [12619]
Weemhoff JL. J Pharm Pharmacol. Mar 2003; 55(3): 381-6
Pubmed [8776]
Wegzyn CM. Curr Opin Pharmacol. Oct 2012; 12(5): 556-61
Pubmed [7207]
Wei L. BMJ. Sep 2011; 343: d5656
Pubmed [5314]
Wei Z. CNS Neurol Disord Drug Targets. Jan 2017; 16(7): 846-853
Pubmed [12310]
Weibrecht, Weigel. Dtsch Med Wochenschr (1976) 101, 20-2 [2406]
Weickert TW. Mol Psychiatry. Jun 2015; 20(6): 685-94
Pubmed [13439]
Weigmann H. Ther Drug Monit. Aug 2001; 23(4): 410-3
Pubmed [2300]
Weiler S, et al. BMJ. Sep 2013; 2: 200796
Pubmed [12915]
Weiler S. BMJ Case Rep. Sep 2013; 2013
Pubmed [12916]
Weinberger M. Pediatrics. Feb 1978; 61(2): 324-5
Pubmed [5974]
Weiner M. Effect of centrally active drugs on the action of coumarine anticoagulants. Nature (1966) 212, 1599-1600 [648]
Weinstock RS. South Med J. Dec 1990; 83(12): 1475-7
Pubmed [12387]
Weintraub D. Arch Neurol. Sep 2005; 62(9): 1432-6
Pubmed [1628]
Weiser M. Int J Geriatr Psychiatry. Apr 2002; 17(4): 343-6
Pubmed [9812]
Weiss J. Eur J Pharmacol. Jan 2008; 579(1-3): 104-9
Pubmed [4475]
Weiss J. J Pharmacol Exp Ther. Apr 2003; 305(1): 197-204
Pubmed [4663]
Weiss MD. J Am Acad Child Adolesc Psychiatry. May 2006; 45(5): 512-519
Pubmed [11711]
Welker HA. Clin Pharmacokinet. Dec 1998; 35(6): 405-23
Pubmed [11962]
Welling PG. Br J Clin Pharmacol. Nov 1979; 8(5): 491-5
Pubmed , Volltext [5175]
Wellington K. Drugs. Jan 2001; 61(15): 2231-40; discussion 2241-2
Pubmed [8257]
Wells BG. Eur J Clin Pharmacol. Jan 1986; 31(3): 285-90
Pubmed [1578]
Wells PS. Ann Intern Med. Nov 1994; 121(9): 676-83
Pubmed [6839]